📰 Daily Current Affairs | 25 June 2026
Indian Pharmacopoeia 2026 Sets Blood Standards
World's First | 10th Edition | Blood Components | IPC | J.P. Nadda
The Indian Pharmacopoeia (IP) 2026 is the first pharmacopoeia in the world to set exclusive standards for blood and blood components. It was released on 2 January 2026 in New Delhi by Union Health Minister J. P. Nadda. The 10th edition of the Indian Pharmacopoeia includes 20 new monographs and 2 revised monographs for blood-related quality standards.
📚 Indian Pharmacopoeia and Monographs
The Indian Pharmacopoeia is the official book of standards for medicines and related substances in India. A monograph in pharmacopoeial usage is a legally recognised specification that defines identity, purity, strength, and quality parameters for a substance or product.
🩸 Blood and Blood Component Standards
The new standards cover blood and blood components used in transfusion services. These standards are legally enforceable in India and are aligned with the Directorate General of Health Services manual and other international guidelines. The standards are intended to support quality assurance in blood banking and to reduce blood transfusion-transmitted infections.
🏥 Indian Pharmacopoeia Commission
The Indian Pharmacopoeia Commission (IPC) is an autonomous institution under the Ministry of Health and Family Welfare. It develops and revises pharmacopoeial standards in India. The Commission is based at Ghaziabad in Uttar Pradesh.
🎓 Conference on Implementation
The Indian Pharmacopoeia Commission organised a national conference at its Ghaziabad campus on 24–25 June 2026. More than 160 participants attended, including blood centre professionals, quality assurance officers, state licensing authorities, and government health officials from Uttar Pradesh, Rajasthan, and Punjab. Harsh Mangla, Joint Secretary in the Union health ministry, addressed the conference virtually.
⭐ Important Facts for Exams
- Indian Pharmacopoeia 2026 is the 10th edition — world's first to set exclusive standards for blood and blood components.
- The Indian Pharmacopoeia Commission (IPC) functions under the Ministry of Health and Family Welfare.
- Blood transfusion-transmitted infections are infections spread through contaminated blood or blood components.
- A monograph in pharmacopoeial usage defines official quality standards (identity, purity, strength) for substances.
- IP 2026 was released by J. P. Nadda (Union Health Minister) on 2 January 2026.
- IPC is based in Ghaziabad, Uttar Pradesh; the national conference had 160+ participants on 24–25 June 2026.
📝 Practice Questions
Q1. Which edition of the Indian Pharmacopoeia was released in January 2026?
a) 8th edition b) 9th edition c) 10th edition d) 11th edition
✅ Correct Answer: c) 10th edition
Q2. The Indian Pharmacopoeia 2026 is the first pharmacopoeia in the world to set standards for what?
a) Herbal medicines b) Vaccines c) Blood and blood components d) Antibiotics
✅ Correct Answer: c) Blood and blood components
Q3. Where is the Indian Pharmacopoeia Commission (IPC) headquartered?
a) New Delhi b) Mumbai c) Ghaziabad d) Hyderabad
✅ Correct Answer: c) Ghaziabad
Q4. Under which ministry does the Indian Pharmacopoeia Commission function?
a) Ministry of Science and Technology b) Ministry of Health and Family Welfare c) Ministry of Commerce d) Ministry of Education
✅ Correct Answer: b) Ministry of Health and Family Welfare
Q5. Who released the Indian Pharmacopoeia 2026 on 2 January 2026?
a) PM Narendra Modi b) J.P. Nadda c) Mansukh Mandaviya d) Harsh Vardhan
✅ Correct Answer: b) J.P. Nadda
